AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...
1 Beijing Key Laboratory of Mental Disorders, National Clinical Research Centre for Mental Disorders ... The ASI-3 was used to evaluate AS and fear of anxiety-related symptoms (20). It comprises 18 ...